MAPK1 and colorectal carcinoma: Furthermore, miR-769-5p targets and inhibits MAPK1 in CRC cells, which blocks the cell cycle and induces CRC cells to enter the quiescent phase, thereby promoting stemness and chemotherapy resistance.